about
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribineUnexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitisFine-mapping resolves Eae23 into two QTLs and implicates ZEB1 as a candidate gene regulating experimental neuroinflammation in rat.Eae19, a new locus on rat chromosome 15 regulating experimental autoimmune encephalomyelitis.Mononeuritis multiplex as the first presentation of refractory sarcoidosis responsive to etanerceptBiomarker report from the phase II lamotrigine trial in secondary progressive MS - neurofilament as a surrogate of disease progression.Development of resistance to biologic therapies with reference to IFN-β.The role of infections in Behçet disease and neuro-Behçet syndrome.Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis.Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.Deep Sequencing of HIV-1 in Cerebrospinal Fluid.Do neutralising antibodies against exogenous interferon-beta inhibit endogenous signalling pathways?A whole genome association study in multiple sclerosis patients from north Portugal.Vitamin D deficiency--do we follow our own advice?Alemtuzumab depletion failure can occur in multiple sclerosis.Acute treatment with valproic acid and l-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats.Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.Switching patients at high risk of PML from natalizumab to another disease-modifying therapy.Recurrent cerebrospinal fluid escape in an HIV-1-infected patient receiving antiretroviral therapy.Anti-MOG antibodies are under polygenic regulation with the most significant control coming from the C-type lectin-like gene locus.Resolution of a 16.8-Mb autoimmunity-regulating rat chromosome 4 region into multiple encephalomyelitis quantitative trait loci and evidence for epistasis.The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis populationMultiple loci comprising immune-related genes regulate experimental neuroinflammationIgG4-related disease: a rare but treatable cause of refractory intracranial hypertensionTNF Production in Macrophages Is Genetically Determined and Regulates Inflammatory Disease in RatsToll-like Receptors in Multiple Sclerosis Mouse Experimental ModelsVisibility and representation of women in multiple sclerosis research.Disease modification in advanced MS: Focus on upper limb functionNo evidence of disease activity in people with multiple sclerosisTreating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policies
P50
Q28268596-743EE6ED-63CC-4547-968F-06805F06B86BQ28591514-C13B2861-C60F-4BCF-AD6D-74D339D66A53Q33697723-89C63BE0-D929-47A1-9F26-B388FF3DB029Q34573223-91B4E9A1-E189-4E50-B952-FAA162F6CDCAQ34768871-B2B3E0AD-37AD-44C5-81CD-46BDB536A5A0Q34924891-E6FC785F-7D89-476A-A778-0F205D489493Q37976978-5DDC624A-EC84-4433-930E-DF7BA0D2B20CQ38377131-8ECB523D-8B19-48B2-96E1-CCCE1DD542AAQ39119839-826959DD-28A8-4BA8-8151-BAC0446AD85DQ40431316-707AB75A-8F86-4402-9ACE-B9D4BF5F540DQ41197031-ED9A3FA2-ED31-4DDD-88E6-97EBD65183E3Q42154007-72EE60F6-A6AC-4186-8D6C-6DFD6BC0C420Q43705917-F10C3813-8F0A-41AE-801E-A0D3ED97CD39Q46306415-4308182C-C402-436F-97B4-560D088CB3B0Q48106234-7379DEDD-3DAE-4F20-A045-97ABD6B86722Q48590059-5B366786-C527-4710-9FAE-72A7B5CF3764Q50597243-515BF214-D72A-4764-9692-0B5537410D8CQ50858454-98112385-8F63-4850-A437-2CFB6642E119Q50877066-F2C3E64F-CD13-48B3-84A6-BEF3A69C336CQ50893300-EE3B49AC-9904-40A7-9FF5-51DE70C24B78Q53875124-860A645B-B702-44F1-95E1-022FF2438908Q57526251-D91340DC-CB8E-4FF7-8A98-6608D79B6883Q59831106-43AEAA0F-A90A-48BB-9624-5366792F675DQ61479111-DE4348A1-19A4-4E07-85FC-88426A97F8A3Q61479147-C40773F5-C214-443F-9D9A-2CADF9B7F0E0Q61479150-2330D271-D040-482F-85F3-BED1778BCE0AQ64936207-579619AD-A1D1-4EEA-A0D1-B246B9E7E85BQ88432538-7081E80A-A8D2-4989-88DE-77DF3A605D70Q90917794-3093DA95-B308-4162-A396-DCD65703A2BFQ93009029-F64F9EFC-4D58-4226-B1FC-BCED1B005973
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Monica Marta
@ast
Monica Marta
@en
Monica Marta
@es
Monica Marta
@nl
Monica Marta
@sl
type
label
Monica Marta
@ast
Monica Marta
@en
Monica Marta
@es
Monica Marta
@nl
Monica Marta
@sl
altLabel
Monica Calado Marta
@en
prefLabel
Monica Marta
@ast
Monica Marta
@en
Monica Marta
@es
Monica Marta
@nl
Monica Marta
@sl
P108
P106
P1153
8578393000
P21
P31
P496
0000-0002-5464-9070
P569
2000-01-01T00:00:00Z